• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

    12/13/24 5:07:48 PM ET
    $MODV
    Transportation Services
    Consumer Discretionary
    Get the next $MODV alert in real time by email
    SC 13D/A 1 d853017dsc13da.htm SC 13D/A SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 23)*

     

     

    ModivCare Inc.

    (Name of Issuer)

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)

    743815102

    (CUSIP Number)

    Christopher Shackelton/Adam Gray

    105 Rowayton Avenue

    Rowayton, CT 06853

    with a copy to:

    Debevoise & Plimpton LLP

    Attention: William D. Regner, Esq.

    66 Hudson Boulevard

    New York, NY 10001

    (212) 909-6000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    December 13, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §240.13d-1(e), §240.13d-1(f) or §240.13d-1(g), check the following box. ☐

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 743815102    13D/A    Page 2 of 10

     

     1.    

     Names of reporting persons.

     

     Coliseum Capital Management, LLC

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     AF

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     2,982,751

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     2,982,751

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     2,982,751

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     20.9%

    14.  

     Type of reporting person (see instructions)

     

     IA


    CUSIP No. 743815102    13D/A    Page 3 of 10

     

     1.    

     Names of reporting persons.

     

     Coliseum Capital, LLC

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     AF

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     2,344,778

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     2,344,778

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     2,344,778

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     16.4%

    14.  

     Type of reporting person (see instructions)

     

     OO


    CUSIP No. 743815102    13D/A    Page 4 of 10

     

     1.    

     Names of reporting persons.

     

     Coliseum Capital Partners, L.P.

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     WC

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     2,231,441

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     2,231,441

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     2,231,441

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     15.6%

    14.  

     Type of reporting person (see instructions)

     

     PN


    CUSIP No. 743815102    13D/A    Page 5 of 10

     

     1.    

     Names of reporting persons.

     

     Coliseum Capital Partners II, L.P.

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     WC

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     Delaware

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     113,337

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     113,337

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     113,337

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     0.8%

    14.  

     Type of reporting person (see instructions)

     

     PN


    CUSIP No. 743815102    13D/A    Page 6 of 10

     

     1.    

     Names of reporting persons.

     

     Adam Gray

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     AF

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     United States

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     2,982,751

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     2,982,751

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     2,982,751

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     20.9%

    14.  

     Type of reporting person (see instructions)

     

     IN


    CUSIP No. 743815102    13D/A    Page 7 of 10

     

     1.    

     Names of reporting persons.

     

     Christopher Shackelton

     2.  

     Check the appropriate box if a member of a group (see instructions)

     (a) ☐  (b) ☒

     

     3.  

     SEC use only

     

     4.  

     Source of funds (see instructions)

     

     AF

     5.  

     Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

     ☐

     6.  

     Citizenship or place of organization

     

     United States

    Number of

    shares  beneficially 

    owned by

    each

    reporting

    person

    with

     

        7.     

     Sole voting power

     

     0

        8.   

     Shared voting power

     

     2,982,751

        9.   

     Sole dispositive power

     

     0

       10.   

     Shared dispositive power

     

     2,982,751

    11.    

     Aggregate amount beneficially owned by each reporting person

     

     2,982,751

    12.  

     Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

     ☐

    13.  

     Percent of class represented by amount in Row (11)

     

     20.9%

    14.  

     Type of reporting person (see instructions)

     

     IN


    CUSIP No. 743815102    13D/A    Page 8 of 10

     

    Explanatory Note: This Amendment No. 23 (this “Amendment”) to the Schedule 13D (the “Initial 13D”) relating to the common stock, par value $0.001 per share (“Common Stock”) of ModivCare Inc. (the “Issuer”), filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on July 30, 2012 and as amended and supplemented by Amendment No. 1 to the Initial 13D filed on August 20, 2012, Amendment No. 2 to the Initial 13D filed on September 13, 2012, Amendment No. 3 to the Initial 13D filed on November 28, 2012, Amendment No. 4 to the Initial 13D filed on August 15, 2013, Amendment No. 5 to the Initial 13D filed on October 28, 2014, Amendment No. 6 to the Initial 13D filed on February 23, 2015, Amendment No. 7 to the Initial 13D filed on March 16, 2015, Amendment No. 8 to the Initial 13D filed on March 17, 2017, Amendment No. 9 to the Initial 13D filed on December 13, 2017, Amendment No. 10 to the Initial 13D filed on May 10, 2018, Amendment No. 11 to the Initial 13D filed on June 1, 2018, Amendment No. 12 to the Initial 13D filed on June 7, 2018, Amendment No. 13 to the Initial 13D filed on November 14, 2019, Amendment No. 14 to the Initial 13D filed on June 12, 2020, and Amendment No. 15 to the Initial 13D filed on November 12, 2020, Amendment No. 16 to the Initial 13D filed on September 9, 2021, Amendment No. 17 to the Initial 13D filed on May 10, 2023, Amendment No. 18 to the Initial 13D filed on August 10, 2023, Amendment No. 19 to the Initial 13D filed on August 11, 2023, Amendment No. 20 to the Initial 13D filed on September 11, 2023, Amendment No. 21 to the Initial 13D filed on September 13, 2023, and Amendment No. 22 to the Initial 13D filed on September 18, 2023, amends and supplements certain of the items set forth therein.

    As used in this Amendment, the term “Reporting Persons” collectively refers to:

    Coliseum Capital Management, LLC, a Delaware limited liability company (“CCM”);

    Coliseum Capital, LLC, a Delaware limited liability company (“CC”);

    Coliseum Capital Partners, L.P., a Delaware limited partnership (“CCP”);

    Coliseum Capital Partners II, L.P., a Delaware limited partnership (“CCP2”);

    Adam Gray (“Gray”); and

    Christopher Shackelton, a director of the Issuer (“Shackelton”).

    Item 4. Purpose of Transaction.

    Item 4 is hereby amended and supplemented as follows:

    On December 13, 2024, Shackelton notified the board of directors of the Issuer (the “Board”) of his intention to resign as a director, effective December 13, 2024. The Reporting Persons remain supportive of the Board and the Issuer’s management.

    The Reporting Persons acquired the Common Stock and the Issuer’s debt securities for investment purposes, and such purchases were made in the Reporting Persons’ ordinary course of business. In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock, the Issuer’s debt securities or other securities or derivative or other instruments that are based upon or relate to the value of securities of the Issuer, and in such manner, as they deem advisable to benefit from changes in market prices of the Common Stock or the Issuer’s debt securities, changes in the Issuer’s operations, business strategy or prospects, or from an acquisition, sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons routinely will monitor the Issuer’s operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as alternative investment opportunities, liquidity requirements of the Reporting Persons and other investment considerations. Consistent with their investment research methods and evaluation criteria, the Reporting Persons may discuss such matters with management or directors of the Issuer, other shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other investors. Such factors and discussions may materially affect, and result in, the Reporting Persons’ modifying their ownership of the Common Stock and the Issuer’s debt securities, exchanging information with the Issuer pursuant to appropriate confidentiality or similar agreements, proposing changes in the Issuer’s operations, governance or capitalization, or in proposing one or more of the other actions described in paragraphs (a) through (j) of Item 4 of Schedule. The Reporting Persons reserve the right to formulate other plans and/or make other proposals and take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in paragraphs (a) through (j) of Item 4 of Schedule 13D, or acquire additional Common Stock or additional amounts of the Issuer’s debt securities or dispose of all Common Stock or Issuer’s debt securities beneficially owned by them, in public market or privately negotiated transactions. The Reporting Persons may at any time reconsider and change their plans or proposals relating to the foregoing. The Reporting Persons may also take steps to explore and prepare for various plans and actions, and propose transactions, before forming an intention to engage in such plans or actions or proceed with such transactions.

    Item 5. Interest in Securities of the Issuer.

    Item 5 is hereby amended and supplemented as follows:

     

    (a)-(b)

    The information relating to the beneficial ownership of Common Stock by each of the Reporting Persons and their respective voting powers and disposition powers set forth in Rows 7 through 13 of the cover pages hereto is incorporated herein by reference. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 14,283,664 shares of Common Stock outstanding as of November 1, 2024, as reported in the Issuer’s Quarterly Report on Form 10-Q, as filed with the SEC on November 7, 2024.


    CUSIP No. 743815102    13D/A    Page 9 of 10

     

    Item 7. Material to be Filed as Exhibits.

    Item 7 is hereby supplemented as follows:

     

    Exhibit No.   

    Description

    8    Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G


    CUSIP No. 743815102    13D/A    Page 10 of 10

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    DATED: December 13, 2024

     

    COLISEUM CAPITAL MANAGEMENT, LLC    COLISEUM CAPITAL, LLC

    By: /s/ Chivonne Cassar           

      

    By: /s/ Chivonne Cassar           

    Chivonne Cassar, Attorney-in-fact

      

    Chivonne Cassar, Attorney-in-fact

    COLISEUM CAPITAL PARTNERS, L.P.    COLISEUM CAPITAL PARTNERS II, L.P.
    By: Coliseum Capital, LLC, General Partner    By: Coliseum Capital, LLC, General Partner

    By: /s/ Chivonne Cassar           

      

    By: /s/ Chivonne Cassar           

    Chivonne Cassar, Attorney-in-fact

      

    Chivonne Cassar, Attorney-in-fact

    ADAM GRAY    CHRISTOPHER SHACKELTON

    By: /s/ Chivonne Cassar           

      

    By: /s/ Chivonne Cassar           

    Chivonne Cassar, Attorney-in-fact

      

    Chivonne Cassar, Attorney-in-fact

     

    Get the next $MODV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MODV

    DatePrice TargetRatingAnalyst
    8/9/2024$35.00Mkt Perform → Outperform
    Barrington Research
    5/6/2024$50.00Hold → Buy
    Lake Street
    2/23/2024$60.00 → $40.00Buy → Hold
    Deutsche Bank
    2/23/2024$60.00 → $39.00Buy → Hold
    Jefferies
    8/3/2022$145.00Overweight
    Stephens
    2/28/2022$190.00 → $155.00Outperform
    Barrington Research
    2/3/2022$180.00 → $150.00Buy
    Deutsche Bank
    12/17/2021$180.00Buy
    Deutsche Bank
    More analyst ratings

    $MODV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Executive Leadership Transitions as Part of Strategic Business Model Evolution

      Modivcare Inc. (NASDAQ:MODV), a technology-enabled healthcare services company that provides supportive care solutions to address the social determinants of health, today announced the planned departures of two members of its executive leadership team as the company continues to align its structure with its evolving business model and modernization strategy. Barb Gutierrez, Chief Financial Officer, and Jessica Kral, Chief Information Officer, will be departing the company following a period of transition. Barb's and Jessica's departures come as Modivcare evolves its organizational structure in an effort to support the next phase of its modernization strategy—built on the financial and tech

      5/5/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Ai Catalyst Fund, Lp bought $1,677,000 worth of shares (420,000 units at $3.99) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      2/3/25 9:56:40 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Coliseum Capital Management, Llc bought $9,995,856 worth of shares (1,502,424 units at $6.65) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/14/25 7:32:58 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Large owner Q Global Capital Management, L.P. bought $48,385 worth of shares (3,837 units at $12.61) and sold $5,400,260 worth of shares (749,002 units at $7.21) (SEC Form 4)

      4 - ModivCare Inc (0001220754) (Issuer)

      1/13/25 6:35:04 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Financials

    Live finance-specific insights

    See more
    • Modivcare Reports First Quarter 2025 Financial Results

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va

      5/8/25 4:53:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare to Report First Quarter 2025 Financial Results

      Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even

      4/28/25 4:05:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Reports Fourth Quarter and Full Year 2024 Financial Results; Announces Changes to the Board of Directors

      Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0

      3/6/25 4:23:00 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    SEC Filings

    See more
    • ModivCare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - ModivCare Inc (0001220754) (Filer)

      5/8/25 4:52:15 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 8-K filed by ModivCare Inc.

      8-K - ModivCare Inc (0001220754) (Filer)

      5/5/25 6:34:16 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form DEFA14A filed by ModivCare Inc.

      DEFA14A - ModivCare Inc (0001220754) (Filer)

      4/30/25 4:57:23 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 9:05:42 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/13/24 5:07:48 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by ModivCare Inc.

      SC 13D/A - ModivCare Inc (0001220754) (Subject)

      12/9/24 7:46:13 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ModivCare upgraded by Barrington Research with a new price target

      Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00

      8/9/24 9:17:22 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare upgraded by Lake Street with a new price target

      Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00

      5/6/24 8:28:24 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • ModivCare downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously

      2/23/24 7:11:03 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Silvers Daniel B.

      3 - ModivCare Inc (0001220754) (Issuer)

      4/28/25 7:00:13 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • New insider Mounts Gonzales David claimed ownership of 2,130,000 shares (SEC Form 3)

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:46:20 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Cunningham Alexander R.

      3 - ModivCare Inc (0001220754) (Issuer)

      3/17/25 4:33:30 PM ET
      $MODV
      Transportation Services
      Consumer Discretionary

    $MODV
    Leadership Updates

    Live Leadership Updates

    See more
    • Modivcare Announces Changes to Board of Directors

      Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Daniel Silvers has been appointed to its board of directors (the "Board"), effective April 24, 2025. The appointment of Mr. Silvers completes the Board's previously announced plan to add three new independent directors pursuant to its contractual obligations with its lenders. "We welcome Mr. Silvers to the Board and are confide

      4/25/25 6:30:00 AM ET
      $MODV
      Transportation Services
      Consumer Discretionary
    • Modivcare Announces Changes to Board of Directors

      Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern

      2/14/25 6:00:00 AM ET
      $EHTH
      $KAI
      $MODV
      $TVTY
      Specialty Insurers
      Finance
      Industrial Machinery/Components
      Industrials
    • GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600

      NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema

      3/27/24 6:12:00 PM ET
      $FOXF
      $GE
      $MMM
      $MODV
      Motor Vehicles
      Consumer Discretionary
      Consumer Electronics/Appliances
      Technology